Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15


The small FOXP1 isoform predominantly expressed in activated B cell-like diffuse large B-cell lymphoma and full-length FOXP1 exert similar oncogenic and transcriptional activity in human B cells.

van Keimpema M, Gr√ľneberg LJ, Schilder-Tol EJ, Oud ME, Beuling EA, Hensbergen PJ, de Jong J, Pals ST, Spaargaren M.

Haematologica. 2017 Mar;102(3):573-583. doi: 10.3324/haematol.2016.156455. Epub 2016 Dec 1.


B-Lymphoblastic Lymphomas Evolving from Follicular Lymphomas Co-Express Surrogate Light Chains and Mutated Gamma Heavy Chains.

Slot LM, Hoogeboom R, Smit LA, Wormhoudt TA, Biemond BJ, Oud ME, Schilder-Tol EJ, Mulder AB, Jongejan A, van Kampen AH, Kluin PM, Guikema JE, Bende RJ, van Noesel CJ.

Am J Pathol. 2016 Dec;186(12):3273-3284. doi: 10.1016/j.ajpath.2016.07.027. Epub 2016 Oct 15.


High prevalence of oncogenic MYD88 and CD79B mutations in primary testicular diffuse large B-cell lymphoma.

Kraan W, van Keimpema M, Horlings HM, Schilder-Tol EJ, Oud ME, Noorduyn LA, Kluin PM, Kersten MJ, Spaargaren M, Pals ST.

Leukemia. 2014 Mar;28(3):719-20. doi: 10.1038/leu.2013.348. Epub 2013 Nov 20. No abstract available.


High prevalence of oncogenic MYD88 and CD79B mutations in diffuse large B-cell lymphomas presenting at immune-privileged sites.

Kraan W, Horlings HM, van Keimpema M, Schilder-Tol EJ, Oud ME, Scheepstra C, Kluin PM, Kersten MJ, Spaargaren M, Pals ST.

Blood Cancer J. 2013 Sep 6;3:e139. doi: 10.1038/bcj.2013.28.


Illegitimate WNT pathway activation by beta-catenin mutation or autocrine stimulation in T-cell malignancies.

Groen RW, Oud ME, Schilder-Tol EJ, Overdijk MB, ten Berge D, Nusse R, Spaargaren M, Pals ST.

Cancer Res. 2008 Sep 1;68(17):6969-77. doi: 10.1158/0008-5472.CAN-08-1322.


Stimulated plasmacytoid dendritic cells impair human T-cell development.

Schmidlin H, Dontje W, Groot F, Ligthart SJ, Colantonio AD, Oud ME, Schilder-Tol EJ, Spaargaren M, Spits H, Uittenbogaart CH, Blom B.

Blood. 2006 Dec 1;108(12):3792-800. Epub 2006 Aug 17.


The immune dysregulatory compound mercuric chloride induces integrin-mediated T-lymphocyte adhesion.

Roos A, Neeft M, Engelen L, Schilder-Tol EJ, Kunzendorf U, Weening JJ, Aten J.

Immunology. 2001 Jan;102(1):31-8.


Strong and selective glomerular localization of CD134 ligand and TNF receptor-1 in proliferative lupus nephritis.

Aten J, Roos A, Claessen N, Schilder-Tol EJ, Ten Berge IJ, Weening JJ.

J Am Soc Nephrol. 2000 Aug;11(8):1426-38.


Cross-talk between CD44 and c-Met in B cells.

Taher TE, van der Voort R, Smit L, Keehnen RM, Schilder-Tol EJ, Spaargaren M, Pals ST.

Curr Top Microbiol Immunol. 1999;246:31-7; discussion 38. Review. No abstract available.


Strong expression of CD134 (OX40), a member of the TNF receptor family, in a T helper 2-type cytokine environment.

Roos A, Schilder-Tol EJ, Weening JJ, Aten J.

J Leukoc Biol. 1998 Oct;64(4):503-10.


Differential regulation of expression of the MHC class II molecules RT1.B and RT1.D on rat B lymphocytes: effects of interleukin-4, interleukin-13 and interferon-gamma.

Roos A, Schilder-Tol EJ, Chand MA, Claessen N, Lakkis FG, Pascual DW, Weening JJ, Aten J.

Immunology. 1998 Jan;93(1):33-40.


Thiol levels in CD134-defined subsets of rat T lymphocytes: possible implications for HgCl2-induced immune dysregulation.

Roos A, Claessen N, Schilder-Tol EJ, Chand MA, Weening JJ, Aten J.

Biochem Biophys Res Commun. 1997 Nov 17;240(2):452-7.


HgCl2 and IL4 differentially modify expression of major histocompatibility complex class II molecules RT1.B and RT1.D in B lymphocytes from brown Norway and Lewis rats.

Roos A, Schilder-Tol EJ, Chand MA, Weening JJ, Aten J.

Transplant Proc. 1997 May;29(3):1675-6. No abstract available.


Signaling through CD44 is mediated by tyrosine kinases. Association with p56lck in T lymphocytes.

Taher TE, Smit L, Griffioen AW, Schilder-Tol EJ, Borst J, Pals ST.

J Biol Chem. 1996 Feb 2;271(5):2863-7.

Supplemental Content

Loading ...
Support Center